![]() |
|
|
,**



*
Center for Environmental and Genetic Medicine, Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, TX 77030;
Center for Human Molecular Genetics, University of Nebraska Medical Center, Omaha, NE 68198;
**
National Veterinary Research Institute, 24-100 Pulawy, Poland; and
National Center for Toxicological Research, Division of Biochemical Toxicology, Jefferson, AR 72079
3To whom correspondence should be addressed. E-mail: rfinnell{at}ibt.tamu.edu.
Periconceptional folic acid supplementation has been shown to prevent up to 70% of neural tube and other birth defects in humans; however, the mechanism is still unknown. In this study, we tested whether defective intracellular folate transport, as achieved by inactivation of the murine folate-binding protein 1 (Folbp1), affects global DNA methylation in the liver and brain from gestational day (GD) 15
embryos. Complete Folbp1 inactivation is embryolethal but can be reversed by maternal folinic acid (FA) supplementation, and thus we also tested the effect of FA supplementation on DNA methylation in Folbp1 fetuses. Overall, the extent of global DNA methylation seems to be similar across all genotypes in unsupplemented control Folbp1 mice; however, explicit conclusions regarding Folbp1-/- fetuses were not possible because only a single living unsupplemented fetus was viable at GD 15
. FA supplementation induced global DNA hypomethylation across all genotypes. FA-induced hypomethylation is most likely due to its ability to inhibit the enzyme glycine hydroxymethyltransferase, thereby inhibiting the homocysteine remethylation cycle necessary to regenerate S-adenosylmethionine, the methyl donor for DNA methyltransferases. Our hypothesis was that due to defective folate transport in Folbp1-/- embryos and fetuses, DNA would be hypomethylated, thereby altering the temporal expression of critical genes necessary for normal embryonic development. However, these results suggest that an extended examination of changes in DNA methylation prior to GD 15
is required to unequivocally prove or disprove the hypothesis.
KEY WORDS: Folbp1 DNA methylation folinic acid birth defect mice
This article has been cited by other articles:
![]() |
C. A Hobbs, M. A Cleves, S. Melnyk, W. Zhao, and S J. James Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism Am. J. Clinical Nutrition, January 1, 2005; 81(1): 147 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Stover Nutritional genomics Physiol Genomics, January 15, 2004; 16(2): 161 - 165. [Abstract] [Full Text] [PDF] |
||||